These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Relative involvement of receptor subtypes in opioid-induced inhibition of intestinal motility in mice.
    Author: Ward SJ, Takemori AE.
    Journal: Life Sci; ; 31(12-13):1267-70. PubMed ID: 6128653.
    Abstract:
    The effects of opioids on intestinal transit of a charcoal meal were assessed in mice. Morphine (s.c. or i.c.v.) produced a fulldose-response curve and DADLE (s.c. or i.c.v.) produced a dose-response curve with a reduced maximum effect. The highly selective, non-equilibrium mu antagonist, beta-funaltrexamine (beta-FNA), antagonized these effects. Nalorphine (s.c.) induced a maximal 42% inhibition of charcoal meal transit that was not antagonized by beta-FNA. Ethylketazocine (s.c.) produced a full dose-response curve, the higher doses of which were antagonized by beta-FNA. Nalorphine and ethylketazocine had no effect upon charcoal meal transit when given i.c.v.. Tolerance to morphine (s.c.) and to higher doses of ethylketazocine (s.c.) was seen in animals pretreated with a morphine pellet. These data suggest that inhibition of charcoal meal transit in mice can be mediated by a central and a peripheral mu-mediated mechanism and that a peripheral k component may also produce a limited inhibition of intestinal motility. Moreover, since a s.c. dose of beta-FNA produced a 10-and 2-fold shift in the ED50 for morphine given s.c. and i.c.v., respectively, yet an i.c.v. dose of beta-FNA produced a 6- and 200-fold shift in the ED50 for morphine given s.c. and i.c.v., respectively, the effects of a s.c. dose of morphine appear to be mediated predominantly by a peripheral, rather than a central, opioid action.
    [Abstract] [Full Text] [Related] [New Search]